Clinical Urine Drug Screen with Reflex to Confirmation by LCMSMS

Urine Screening Test Requisition | Specimen Information | Billing Information | Contact Us | CPT Codes | Print

CLINICAL URINE DRUG SCREEN WITH REFLEX TO CONFIRMATION BY LCMSMS

SAMPLE REPORT: Clinical UDS with Reflex to Confirmation

TURNAROUND TIME: 3 - 4 days

PERFORMED: Monday through Friday

TESTING METHODOLOGY: High Performance Liquid Chromatography Triple Quadrupole Mass Spectrometer (LC/MSMS).

SPECIMEN REQUIREMENTS:

  • Collect: 20mLS random urine collected in sterile cup. Transfer 10 mL into two vacuette urine containers with no additive or preservative.
  • Min. Collection: 0.5mL in a single vacuette urine container (10mL).
  • Transport: Room Temperature; Store refrigerated if analysis is not performed immediately.
  • Stability: Ambient: 7 days; Refrigerated: 14 days; frozen: 4 months.
  • Unacceptable Conditions: Specimens exposed to repeated freeze/thaw cycles or transferred into a tube or cup containing additives or preservatives.

REFERENCE INTERVAL: Analyte/Metabolite Positive Cutoffs and Reportable Reference Ranges for Confirmation.

Urine Drug Confirmations

Analyte Confirmations Cutoff (ng/mL) Reportable Range (ng/mL) Footnote
*2-oxo-LSD (LSD metabolite) 5 5 - 250
6-MAM (Heroine Metabolite) 10 10 - 500
Alprazolam
*a-hydroxyalprazolam
50
50
50 - 2500
50 - 2500
Amobarbital/ Pentobarbital 100 100 - 5000
Amphetamine 100 100 - 5000
Benzoylecgonine (BE) 50 50 - 2500
Buprenorphine
*Norbuprenorphine
5
20
5 - 250
20 - 1000
Butalbital 100 100 - 5000
Carisoprodol 50 50 - 2500
Clonazepam
*7-aminoclonazepam
50
50
50 - 2500
50 - 2500
Codeine 50 50 - 2500
Cyclobenzaprine
*N-desmethylcyclobenzaprine
50
50
50 - 2500
50 - 2500
Diazepam
*Nordiazepam
50
50
50 - 2500
50 - 2500
Diphenhydramine 50 50 - 2500
Fentanyl
*Norfentanyl
2
10
2 - 100
10 - 500
Flunitrazepam
*7-aminoflunitrazepam
50
50
50 - 2500
50 - 2500
Flurazepam
*Des-alkyl-flurazepam
50
50
50 - 2500
50 - 2500
Gabapentin 500 500 - 25000
Hydrocodone
*Norhydrocodone
50
50
50 - 2500
50 - 2500
Hydromorphone 50 50 - 2500
Lorazepam 50 50 - 2500
Ketamine 50 50 - 2500
MDA 100 100 - 5000
MDEA 100 100 - 5000
MDMA 100 100 - 5000
Meperidine
*Normeperidine
50
50
50 - 2500
50 - 2500
Meprobamate 50 50 - 2500
Methadone
*EDDP
50
50
50 - 2500
50 - 2500
Methamphetamine 100 100 - 5000 i
Methylphenidate
*Ritalinic Acid
50
50
50 - 2500
50 - 2500
Midazolam 50 50 - 2500
Morphine 50 50 - 2500
Naloxone 50 50 - 2500
Naltrexone 50 50 - 2500
Oxazepam 50 50 - 2500
Oxycodone
*Noroxycodone
50
50
50 - 2500
50 - 2500
Oxymorphone 50 50 - 2500
Phencyclidine (PCP) 25 25 - 1250
Phenobarbital 100 100 - 5000
Phentermine 20 20-1000
Pregabalin 500 500 - 25000
Pseudoephedrine 20 20-1000
Secobarbital 100 100 - 5000
Tapentadol
*N-desmethyltapentadol
50
50
50 - 2500
50 - 2500
Temazepam 50 50 - 2500
THC-COOH 25 25 - 1250 ii
Tramadol
*O-desmethyltramadol
50
50
50 - 2500
50 - 2500
Triazolam
*a-hydroxytriazolam
50
50
50 - 2500
50 - 2500
Zolpidem
*Zolpidem - COOH
20
20
20 – 1000
20 - 1000

*Metabolite(s)

iMethamphetamine exists in the d- and l- isomeric forms. Illegal, street-manufactured methamphetamine is the d-isomer, or a racemic mixture of the d and l, with the d- isomer being present at 20-100%. The d- isomer also comes from the prescription drugs Desoxyn and Didrex. L-methamphetamine occurs in the Vick’s inhaler, and as a metabolite of the Parkinson’s drug Eldepryl. This test does not distinguish between d- and l- isomers. If isomer separation is desired contact the laboratory.

ii The drug analyte detected in this assay, 9-carboxy THC, is a metabolite of delta-9-tetrahydrahydrocannabinol (THC). Detection of 9-carboxy THC suggests use of, or exposure to, a product containing THC. This test cannot distinguish between prescribed or non-prescribed forms of THC, nor can it distinguish between active or passive use. The 9-carboxy THC metabolite can be detected in urine for several weeks. Normalization of results to creatinine concentration can help document elimination or suggest recent use, when specimens are collected at least one week apart. 11-Nor-9-carboxy-Δ9-THC glucuronide is a major urinary metabolite of Δ9-THC and is not tested.

INTERPRETIVE DATA: Unanticipated negative findings may be the result of non-compliance, timing of specimen collection relative to drug exposure, inter-individual variations in pharmacokinetics, testing limitations, and or diluted or adulterated urine.

Drug metabolism or exposure to multiple drugs can lead to detection of multiple analytes in urine. Pharmaceutical manufacturing impurities can result in low concentrations of an anticipated analyte in the presence of large concentrations of another related analyte.

Specimens for which drugs and drug metabolites are detected by the screen are reflexed to a second more specific confirmatory quantitative procedure by LCMSMS (Liquid Chromatography Tandem Mass Spectrometry). Additional charges may apply.

Interpretive questions should be directed to the laboratory.

ANALYTIC SENSITIVITY:  >99%

TEST LIMITATIONS: Urine creatinine results less than 20 mg/dL may indicate adulterated/ diluted urine. Recollection of urine specimen may be requested and preferably from an early morning clean catch specimen.

INDICATIONS FOR USE: Results are intended to provide physicians/ clients of Saint Francis Health System with clinical interpretation of the results obtained from analysis of a urine specimen for the presence and/or absence of drugs and their metabolites. This test is not intended to be used as a pre-employment screening assay or for legal forensic purposes.

ADDITIONAL RESOURCES: http://www.aruplab.com/pain-management


___________________________

Methamphetamine Footnote
ii THC-COOH Footnote